New Crohn's drug aims to heal gut from the inside out
NCT ID NCT07292012
Summary
This study is testing whether the medication mirikizumab can achieve deep healing of intestinal inflammation in people with active Crohn's disease. It will involve 110 adult participants who have symptoms and visible inflammation on an MRI scan. The main goal is to see if 24 weeks of treatment reduces inflammation by at least 25% in all affected bowel segments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH de Valence
Valence, 26000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Brest - Hôpital de la Cavale Blanche
Brest, 29200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Clermont Ferrand - Hôpital d'Estaing
Clermont-Ferrand, 63003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nîmes Carémeau
Nîmes, 30029, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Toulouse - Hôpital Rangueil
Toulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Mutualiste Monsouris
Paris, 75674, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.